| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.77▲ | 3.71▲ | 3.72▲ | 4.34▼ | 6.25▼ |
| MA10 | 3.76▲ | 3.70▲ | 3.82▼ | 4.79▼ | 9.63▼ |
| MA20 | 3.70▲ | 3.84▼ | 4.00▼ | 6.24▼ | 11.19▼ |
| MA50 | 3.71▲ | 4.24▼ | 4.68▼ | 10.64▼ | 11.27▼ |
| MA100 | 3.89▼ | 4.72▼ | 5.15▼ | 11.32▼ | N/A |
| MA200 | 4.25▼ | 5.16▼ | 8.09▼ | 11.67▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | 0.026▲ | 0.007▲ | 0.001▲ | -1.208▼ |
| RSI | 58.309▲ | 38.517▼ | 30.062▼ | 20.450▼ | 28.148▼ |
| STOCH | 84.590▲ | 48.635 | 20.483 | 8.923▼ | 10.130▼ |
| WILL %R | -8.696▲ | -60.825 | -66.667 | -92.542▼ | -98.314▼ |
| CCI | 58.083 | 35.130 | -47.821 | -173.061▼ | -135.612▼ |
| ▼ RSI&STOCH | $AARD Oversold RSI + Stochastic | Set Alert |
| ▲ MACD | $AARD MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| ▼ BREAK | $AARD Price Breaks 60 Days Low | Set Alert |
| ▼ BREAK | $AARD Price Breaks 30 Days Low | Set Alert |
| ▼ BREAK | $AARD Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $AARD Price Breaks 10 Days Low | Set Alert |
|
Wednesday, March 04, 2026 05:54 AM
Aardvark Therapeutics Inc. AARD on Monday announced to voluntarily pause its Phase 3 HERO trial for Prader-Willi Syndrome. The update has sent the stock plunge almost 61%. The decision comes as the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/03/26 | 4.00 | 4.095 | 3.55 | 3.77 | 461,903 |
| 23/03/26 | 4.06 | 4.17 | 4.0119 | 4.065 | 207,923 |
| 20/03/26 | 4.84 | 4.93 | 4.055 | 4.07 | 436,848 |
| 19/03/26 | 4.84 | 4.98 | 4.80 | 4.90 | 215,667 |
| 18/03/26 | 5.29 | 5.4674 | 4.84 | 4.88 | 382,541 |
| 17/03/26 | 5.40 | 5.46 | 5.2922 | 5.33 | 292,880 |
| 16/03/26 | 5.07 | 5.4899 | 5.00 | 5.36 | 276,774 |
| 13/03/26 | 5.30 | 5.365 | 4.83 | 5.09 | 266,095 |
| 12/03/26 | 5.25 | 5.44 | 5.10 | 5.26 | 283,904 |
| 11/03/26 | 5.74 | 5.93 | 5.10 | 5.20 | 821,729 |
|
|
||||
|
|
||||
|
|